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Human thioredoxin is a polypeptide with thiol groups, possessing reducing 
activity, which is proved to have the ability to reduce active oxygens. This study 
evaluated the effect of human thioredoxin on the ischemia-reperfusion lu g 
injury and the roles of human thioredoxin on active oxygens by chemilumines- 
cence examination. The left hilum of the lung of Japanese white rabbits was 
occluded for 110 minutes and then reperfused for 90 minutes. Ten, 30, 60, and 
90 minutes after reperfusion the right hilum was occluded for 5 minutes and 
the pulmonary functions of the left lung were examined. The animals were 
divided into four groups, three ischemia groups and a sham group (without 
occlusion; n = 6). The ischemia groups received human thioredoxin, 60 mg/kg 
(n = 10), N-acetylcysteine, 150 mg/kg (n = 7), or saline solution (control, n = 
10) during reperfusion. Three rabbits in the human thioredoxin group and the 
control group were used to measure active oxygens with a cypridina luciferin 
analog. An additional group of reperfused lungs (n = 3) that were given 
superoxide dismutase after 110 minutes of ischemia was established toidentify 
chemiluminescence examination. Compared with the sham group, reperfusion 
after 110 minutes of ischemia produced a significant lung injury in the control 
group. Among the ischemia groups, the human thioredoxin group showed 
significantly higher arterial oxygen tension at 30, 60, and 90 minutes after 
reperfusion than the control group, although there was no significant 
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difference between the N-aeetylcysteine and eontrol groups. Histologically, 
intraalveolar exudation, interstitial thickening, and cellular infiltration 
were seen in the control group, whereas in the thioredoxin group alveolar 
structure was weil preserved. In the measurement of active oxygens the 
chemiluminescence in the human thioredoxin group was less than that in 
the control group and as little as that in the group administered superoxide 
dismutase. We concluded human thioredoxin attenuated ischemia-reperfu- 
sion injury by involving active oxygens in rabbit lungs. (J Thorac Cardio- 
vasc Surg 1997;113:1-9) 
T he injury that occurs after blood flow is restored to an ischemic organ has been termed ischemia- 
reperfusion injury and represents a complex multi- 
factorial phenomenon. Organ dysfunction caused by 
ischemia-reperfusion is a pathophysiologic event 
with broad clinical relevance. In the lung it is 
characterized by deterioration of gas exchange, de- 
creased static compliance, and pulmonary edema 
owing to enhanced vascular permeability. 1-3 Early 
• dysfunction of reperfused lung after ischemia re- 
mains a crucial problem in clinical situations, such as 
lung transplantation. The mechanism of this isch- 
emia-reperfusion injury has been extensively inves- 
tigated 4'5 and many studies have suggested that 
active oxygens, including free radicals, play a pivotal 
role in its pathogenesis. 6-9Many attempts have been 
made to ameliorate ischemia-reperfusion lu g in- 
jury by using radical scavengers, uch as superoxide 
dismutase (SOD), 1° catalase, 11 and iron-chelating 
agents. 12 
Thioredoxin is a polypeptide with reducing activ- 
ity mediated by thiol groups. Human thioredoxin 
(hTRX) consists of 104 amino acids with a molecu- 
lar weight of 12,000 D. 13 hTRX has the ability to 
reduce active oxygens in vitro 14 and to affect intra- 
cellular redox reactions. Recently, we 15-17 reported 
the protective effect of hTRX against ischemia- 
reperfusion lung injury in rats and dogs. There is 
also a report that hTRX enhances the intracellular 
redox activity in lymphocytes by increasing uptake of 
/-cystine, an oxidized form of/-cysteine, which is a 
precursor of glutathione. 18 However, how hTRX 
protects against ischemia-reperfusion lung injury 
and whether hTRX has an effect against active 
oxygens in reperfused lung were not clear. 
Because active oxygens are highly reactive 
chemical species, it is not easy to detect rhein, 
especially in in vivo models. Recently, Nakano 19 
reported that one of the cypridina luciferin ana- 
logs, 2-methyl-6-[p-methoxyphenyl]-3,7-dihydro- 
imidazo[1,2-a]pyrazin-3-0ne (MCLA) was a very 
sensitive and specific luminescence probe to de- 
tect active oxygens. MCLA reacts with 0 2- or 10 2 
to emit light, which could be detected from the 
surface of the lung by a sensitive photon 
counter. 2° The objective of this study was to 
examine the protective ffect of hTRX on isch- 
emia-reperfusion lung injury in a rabbit model 
and to investigate the role of hTRX on active 
oxygens with a chemiluminescence m thod. 
Materials and methods 
Animals. Male Japanese white rabbits weighing 3.0 to 
3.5 kg, which were certified to be free of specific patho- 
gens, were used. They received humane care in compli- 
ance with the "Guide for the Care and Use of Laboratory 
Animals" prepared by the Institute of Laboratory Animal 
Resources and published by the National Institutes of 
Health (NIH Publication No. 86-23. revised 1985). 
hTRX. Cyclic deoxyribonucleic a id of hTRX was ex- 
pressed in Escherichia coli, and hTRX protein accumu- 
lated in the bacterial cells was purified by ion-exchange 
chromatography. Then it was fully reduced by treatment 
with dithiothreitol. The resulting sample was more than 
99% pure, as determined by densitometer analysis after 
sodium dodecyl sulfate-polyacrylamide gel lectophoresis 
and silver staining. The content of bacterial endotoxin was
less than 4 pg/mg protein according to the quantitative 
chromogenic Limulus amebocyte lysate method (Ajino- 
moto Co., Inc., Kawasaki, Japan)] 4 
Surgieal preparation. The rabbits were premedicated 
with intramuscular injections of atropine sulfate (0.15 mg) 
and ketamine chloride (150 mg) and anesthetized with 
intravenous injection of thiopental (25 mg/kg). A trache- 
ostomy was performed, and a 4.5F endotracheal tube was 
placed that permitted ventilation with a ventilator (Shi- 
nano Industrial Company, Kyoto, Japan) at 30 breaths/ 
min, a tidal volume of 10 ml/kg, and a positive end- 
expiratory pressure of 2 cm H2O. The inspiratory fraction 
of oxygen was 1.0. Ringer's lactate solution was infused 
and anesthesia was maintained by continuous infusion of 
25 mg thiopental per hour and intravenous injections of 
0.8 mg pancuronium bromide ev ry 30 to 60 minutes. A
warming mat was placed under the animals to maintain 
body temperature. A 20-gauge Surflow tube (Terumo Co., 
Tokyo, Japan) was placed in the femoral rtery to monitor 
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the arterial pressure. The sternum was incised horizon- 
tally, and the thorax was opened bilaterally at the fourth 
intercostal space. After removal of mediastinal tissues and 
pericardiotomy, the inferior pulmonary ligaments were 
divided and the left pulmonary hilum was stripped. After 
an intravenous injection of heparin sodium (1000 U/kg), 
the left hilum, which included the left main bronchus and 
pulmonary artery and veins, was occluded with a rubber 
clip (Double Soft Jaw Handleless Clamp, model CV 5114, 
Baxter Healthcare Corp., Irvine, Calif.) to produce isch- 
emia. Ischemia was imposed on the lung in the deflated 
state. After 110 minutes of occlusion, the rubber clip was 
released and the left lung was reperfused and reventilated 
for 90 minutes. 
Experimental protocol. Thirty-six animals were divided 
into four groups, three ischemia groups and a sham group. 
The ischemia groups were the hTRX group (n = 10), 
whieh received hTRX 60 mg/kg dissolved in saline solu- 
tion, the NAC group (n = 7), which received N-acetylcys- 
teine (NAC) 150 mg/kg dissolved in saline solution, and 
the control group (n = 10), which reeeived saline solution. 
The sham group (n = 6) consisted of rabbits in which the 
left hilum was not occluded; after 110 minutes of bilateral 
ventilation the left lung was examined with saline solution 
to be compared with the control group. The pharmaeo- 
logic agents were administered continuously through a 
central vein over 60 minutes, starting 5 minutes before the 
beginning of reperfusion. 
Three rabbits in the hTRX group and the eontrol group 
were used to evaluate active oxygens by measuring chemi- 
luminescence of reperfused lungs. As a positive control, 
after 110 minutes of isehemia, an additional group of 
reperfused lungs was given SOD (Copper-zine SOD from 
bovine erythroeytes, Sigma Chemical Co., St. Louis, Mo.), 
5 mg/kg (5600 U/mg) (n = 3), in the same way as the other 
groups to identify chemilumineseenee examination. 
Physiologic examination. A 5F flow-directed balloon 
catheter was inserted through the femoral vein, and its tip 
was placed in the main pulmonary artery with a 20 ml/hr 
infusion. Baseline measurement of arterial pressure, pul- 
monary arterial pressure, arterial blood gas analysis, peak 
inspiratory airway pressure, and core temperature were 
made in both lungs before the hilar occlusion. Arterial 
pressure and pulmonary arterial pressure were measured 
with a pressure transducer (Nihon Koden, Tokyo, Japan). 
Arterial blood gas analysis was eonducted with an ABL 
300 analyzer (Radiometer A/S, Copenhagen, Denmark). 
Peak inspiratory pressure was measured with a calibration 
manometer (Siemens AG--Bereich Medizinische Tech- 
nik, Erlangen, Germany). The core temperature was 
measured with a thermometer (COM-1, Baxter). The 
surgical field was covered with wet gauze and plastic wrap 
to maintain body temperature and humidity during iseh- 
emia. After 110 minutes of ischemia the accessory lobe 
was pulled out from the dorsal side of the inferior vena 
cava and placed in the right pleural cavity so that the right 
hilum could be clamped completely. Ten, 30, 60, and 90 
minutes after reperfusion, arterial pressure, pulmonary 
arterial pressure, arterial blood gases, and peak inspira- 
tory pressure were measured in the left lung alone after 
the right hilum had been clamped intermittently for 5 
minutes with a forceps. The animals were put to death 
after the measurements had been made for 90 minutes. 
Ninety minutes after the beginning of reperfusion or 
immediately after death from respiratory failure, the 
upper half of the left lower lobe was weighed as a wet lung 
and then stored at 70 ° C for 72 hours, at which time the 
wet/dry weight ratio was calculated. 
Measurement of lipid peroxides. The upper lobe was 
homogenized and its content of malondialdehyde, which 
is formed by the degradation of lipid peroxides, was 
measured. Malondialdehyde reacts with thiobarbituric 
acid and produces a red substance, the absorbance A535 
of which can be measured by means of a spectrophotom- 
eter. 
Histologic examination. The lower half of the lower 
lobe of the left lung was stained with hematoxylin-eosin 
and examined histologically. 
Chemiluminescence examination. The light emission 
from the surface of the lung was measured by a photo- 
multiplier (R1332, Hamamatsu Photonics, Hamamatsu, 
Japan), responsive in the range of 350 to 650 nm. The 
sensitivity of the photomultiplier was detected by Hast- 
ing's method and found to be 1 cps = about 1500 photons 
per second at a 10 cm distance from the window of the 
photomultiplier. 2° The central venous lines were kept by a 
20-gauge Surflow tube and a 4F tube in the femoral vein 
and the internal jugular vein, respectively, with a total 
infusion of 10 ml/hr. After the left hilar dissection, the 
rabbit was placed in the right semi-decubitus position into 
a special light-tight box so that the left lung was positioned 
10 cm under the window of the photomultiplier. The body 
temperature was kept with the warming mat at 38 ° C, 
which was checked with a thermometer inserted into the 
chest wall on the lefl side. The tubes from the respirator, 
the arterial line, two central venous lines, the heating pad, 
and the thermometer were connected outside through the 
side holes of the instruments. The lung surface was 
exposed through a 3 cm hole in a black cloth, which 
covered the whole animal. The photon was detected 
continuously for 5 seconds. 
MCLA (Tokyo Kasei, Tokyo, Japan) was dissolved in 
saline solution at a concentration of 300/zmol/ml, which 
was based on e430 nm = 9600 mo1-1, cm -1. After the 
bolus injection of 400 nmol/kg, the MCLA was infused 
through the femoral vein at a rate of 400 nmol/kg until the 
end of the experiment. When MCLA was injected into 
the rabbit, a strong burst of luminescence, greater than 
the natural luminescence, was detected from the lung 
surface. Then the luminescence decreased and remained 
constant during continuous infusion of MCLA. The left 
hilum was occluded with the clip more than 20 minutes 
after the bolus injection when the luminescence became 
constant. During ischemia the thorax was covered with 
transparent plastic wrap. After 110 minutes of ischemia, 
the clip was released and the left lung was reperfused and 
reventilated bilaterally. Luminescence was expressed as 
ratlos of photon numbers to the baseline, which was the 
mean number of the photons measured uring 2 minutes 
just before ischemia when the photons were constant. 
Statistical analysis. All values are expressed as mean -+ 
standard error of the mean. Comparisons were made by 
means of analysis of variance and Students' t test. Statis- 
tical signifieance was taken as p < 0.05. Chemilumines- 
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Fig. 1. Arterial oxygen tension (Pao2) at baseline and after reperfusion. Pao 2 in the control group was 
significantly lower after reperfusion than in the sham group. In the hTRX group Pao2 was significantly 
higher at 30, 60, and 90 minutes after reperfusion than in the control group. Values are mean -+ standard 
error of the mean. *p < 0.05 versus control; **p < 0.01 versus control. 
Table I. Survival to 90 minutes after reperfusion, mean arterial pressure, and body temperature on physiologic 
examination 
Arterial pressure (mm Hg)* Temperature (°C) * 
Survival Baseline 90 min Baseline 90 min 
hTRX 7/7 76.5 -+ 4.5 57.1 _+ 3.6 38.3 + 0.1 36.0 _+ 0.2 
NAC 7/7 77.2 +- 2.8 61.1 _+ 7.4 38.6 _+ 0.2 36.3 -+ 0.3 
Control  5/7 75.7 -- 5.9 67.0 +_ 5.5 38.5 -+ 0.1 36.3 +- 0.3 
Sham 6/6 67.5 -+ 5.6 66.4 _+ 8.9 38.3 + 0.3 36.2 -- 0.4 
Values are mean ± standard error of the mean. hTRX, Human thioredoxin; NAC, N-acetylcysteine. 
*There were no significant differences between the control and the sham groups or among the three ischemia groups. 
cence data are shown graphically for each group, and 
areas above the baseline for each group are expressed as 
mean -+ standard error of the mean. 
Results 
Thirty-nine experiments were performed. Hypo- 
tensive rabbits with systolic pressures less than 60 
mm Hg during ischemia were excluded before any 
drugs were added (n = 3), because it was not our 
purpose to assess circulatory impairment resulting 
from ischemia lone. Among 36 experiments, two of 
the seven rabbits in the control group died less than 
90 minutes after the beginning of reperfusion--one 
at 28 minutes and the other at 62 minutes. The last 
blood gas analysis showed low oxygen tension in 
these rabbits. The other rabbits in the hTRX, NAC, 
and sham groups survived for 90 minutes after 
reperfusion (Table I). 
Arterial oxygen tension (Fig. 1). The arterial 
oxygen tensions at baseline and 90 minutes after 
reperfusion in the control group were 505.3 + 16.3 
and 82.6 _+ 11.2 mm Hg, respectively. In the sham 
group the values were 525.3 _+ 16.6 and 501.1 + 26.7 
mm Hg, respectively. The differences were signifi- 
cant at 10 (p < 0.05), 30, 60, and 90 minutes (p < 
0.01). In the hTRX group the oxygen tensions were 
531.6 _+ 5.8 and 296.4 _+ 71.9 mm Hg, respectively, 
and in the NAC group they were 527.9 _+ 10.4 and 
183.8 _+ 51.6 mm Hg, respectively. In the hTRX 
group arterial oxygen tension was significantly 
higher than in the control group at 30, 60, and 90 
min (p < 0.05). No other significant differences were 
observed among the experimental groups. 
Pulmonary functions of reperfused lung (Table 
II). Pulmonary arterial pressure in the control 
group was higher than that in the sham group at 30, 
60, and 90 minutes (p < 0.05) after reperfusion, but 
there were no significant differences among the 
three ischemia groups. Peak inspiratory pressure in 
the control groups was not significantly different 
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Table II. Pulmonary functions of reperfused lungs 
Group Baseline 10 min 30 min 60 min 90 min W/D ratio 
hTRX PAP (mm Hg) 18.4 + 0.7 20.2 _+ 2.3 20.5 _+ 3.1 21.4 + 2.0 23.5 _+ 2.1 
7.68 _+ 0.41 
PIP (cm H20 ) 14.4 _+ 0.7 40.1 -+ 2.3 40.2 _+ 4.9 33.2 + 1.2 33.1 -+ 1.2 
NAC PAP 18.0 _+ 1.1 20.8 __ 2.3 22.4 + 3.0 25.2 _+ 1.8 24.5 _+ 1.5 
8.24 _+ 0.44 
PIP 14.7 + 0.8 33.1 _+ 2.9 34.2 _+ 3.9 34.1 _+ 2.9 37.1 _+ 4.7 
Control PAP 17.5 + 1.2 19.1 -- 1.6 21.6 _+ 1.9" 25.4 -4- 2.3* 25.0 _+ 1.9" 
9.20 -- 0.57t 
PIP 14.3 _+ 0.5 33.5 -+ 2.9 29.6 _+ 1.4 31.1 _+ 2.0 33.13, _+ 1.9 
Sham PAP 14.7 _+ 1.5 16.0 -+ 1.4 16.3 _+ 1.0 16.8 _+ 1.3 16.3 -+ 1.7 
5.85 _+ 0.21 
PIP 15.3 _+ 0.8 33.6 -+ 2.1 32.8 -4- 1.7 30.0 _+ 1.2 29.6 -+ 1.1 
Values are mean -+ standard error of the mean. hTRX, Human thioredoxin; NAC, N-acetylcysteine; PAP, mean pulmonary arterial pressure; PIP, peak 
inspiratory airway pressure; W/D, wet/dry weight ratio. 
*p < 0.05 versus ham. 
tp < 0.01 versus sham. 
from that in the sham group and there were no 
significant differences among the ischemia groups. 
The wet/dry ratio in the control group was signifi- 
cantly higher than in the sham group (p < 0.01). The 
wet/dry ratio in the hTRX group tended to be lower 
than in the control group (p = 0.056), but the 
difference was not significant. The lipid peroxides in 
the tissues after reperfusion were 52.7 _+ 6.1, 61.4 2 
8.5, 52.7 2 6.1, and 55.8 2 16.1 nmol/gm in the 
hTRX, NAC, control, and sham groups, respec- 
tively. There were no significant differences between 
the control and sham groups or among the ischemia 
groups. 
Itistologic examination (Fig. 2). Intraalveolar ex- 
udation was noted, the interstitium was thickened, 
and neutrophil infiltrations were marked in the 
control group. Alveolar exudate was little in the 
NAC group and minimal in the hTRX group. Alve- 
olar architecture was well preserved in both the 
NAC and the hTRX groups. 
Chemiluminescence examination. The time 
courses in photon ratlos in three cases in the control, 
hTRX, and SOD groups are shown in Fig. 3. After 
hilar occlusion, luminescence d creased because blood 
flow had been stopped; then, after reperfusion, it
recovered to the value before ischemia. In the control 
group the photon ratio gradually increased to 2.5 or 
larger within 30 minutes and continued until 90 min- 
utes after reperfusion i all three cases. The photon 
ratlos did not reach 2 within 90 minutes after eperfu- 
sion in either the SOD group or the hTRX group. The 
areas above the baseline, the integral of the photon 
ratlos, in the SOD and hTRX groups are signißcantly 
lower than in the control group (p < 0.05) (Fig. 4). 
Discussion 
hTRX was first discovered as an adult T-cell 
leukemia-derived factor produced by a cell line 
derived from adult T-cell leukemia infected by 
human T-cell leukemia virus type 1 (HTLV-1). 21' 22 
Subsequent purification and gene cloning proved 
that hTRX is a protein with a molecular weight of 
12,000 D, composed of 104 amino acids, 13 and that 
it is a human homo]og of bacterial coenzyme thiore- 
doxin. 23 It is widely distributed in the human body, 
and it is induced by a variety of stresses including 
x-ray, ultraviolet, hydrogen peroxide, mitogen, and 
viral infection. 24 hTRX has a -Cys-Gly-Pro-Cys- 
amino acid sequence, which is a conserved sequence 
forming active site of thioredoxin of all species 
including eukaryotic and prokaryotic organisms. 2s It 
exhibits various biologic activities, such as reducing 
activity through proton donation, active oxygen- 
reducing activity, 14 cytokine-like activity, 26 and reg- 
ulation of gene expression. 27 It is thought that 
hTRX can act as a redox regulating factor. 
Out study was undertaken todetermine the effect 
of hTRX on ischemia-reperfusion njury and on 
active oxygens in an in vivo rabbit lung model. An 
ischemic time of 110 minutes was chosen, because it
produced reliable injury. In this model, arterial 
oxygen tension in the control group was significantly 
lower than that in the sham group. This phenome- 
non appeared to be caused by increased vascular 
permeability and pressure, because in the control 
group pulmonary arterial pressure and the wet/dry 
ratio were significantly higher than those in the 
sham group and pulmonary edema was histologi- 
cally observed. 
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Fig. 2. Microscopic findings of lungs after 110 minutes of hilar occlusion and 90 minutes of reperfusion 
(original magnification xl00, hematoxylin-eosin staining). A, Control group; B, NAC group; C, hTRX 
group. In the control group, intraalveolar exudation was noted, the interstitiurn was thickened, and 
neutrophil infiltrations were marked. In the hTRX group, the exudate was minimal and the alveolar 
architecture was well preserved. 
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Fig. 3. Time courses of chemiluminescence from the lung surface before and after the MCLA infusion 
with 110 minutes of ischemia nd 90 minutes of reperfusion. The left hilum of the lung was occluded after 
the high chemiluminescence caused by a bolus injection (arrows) of MCLA became constant. The photon 
ratio in the control group was 2.5 or higher after eperfusion. The ratios in the SOD and hTRX groups were 
less than 2 after reperfusion. 
NAC is a reducing agent as well as a glutathione 
precursor. It has a thiol group like hTRX and is 
already in clinical use for the treatment of acetamin- 
ophen intoxication 28 or hemorrhagic ystitis owing 
to alkylating agents, 29 the efficacy of which is 
thought to be a radical scavenging action. 3° There- 
lore the protective ffect of hTRX was compared 
with that of NAC. NAC was administered at a dose 
of 150 mg/kg, which has been reported to provide 
salutary effects in experimental nimals 3°' 31 over a 
period of 60 minutes, starting 5 minutes before 
reperfusion, hTRX was administered at a dose of 60 
mg/kg per hour in the same manner as NAC, which 
is equivalent on the basis of weight per hour to the 
one used in our previous experiment. 16We demon- 
strated that hTRX attenuated ischemia-reperfusion 
lung injury but NAC failed to provide protection in 
the rabbit model. Decreases of the arterial oxygen 
tension in the TRX group were significantly less 
than in the control group (p < 0.05), but the arterial 
oxygen tension levels in the NAC group were not 
significantly different from those in the control 
group. Our previous in vivo study in dogs revealed 
the protective ffect of NAC on ischemia-reperfu- 
sion lung injury similar to that of hTRX. There are 
a number of possible explanations for the apparent 
discrepancy between these studies. (1) The rabbit 
species has a much lower level of xanthine oxidase 
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Fig. 4. The areas above the baseline after reperfusion i  
the control, SOD, and hTRX groups (n = 3, each group). 
Areas in the SOD and hTRX groups were significantly 
lower than in the control group. *p < 0.05 versus control. 
than the dog. 6 Therefore, in rabbits, active oxygens 
through xanthine-xanthine oxidase pathway, which 
NAC was supposed to act on, might be less involved 
in the ischemia-reperfusion injury than in dogs. (2) 
The dose and duration of NAC and hTRX might be 
8 Okubo et al. 
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different. NAC was administered for 60 minutes 
instead of 30 minutes, which had been used in our 
previous study, 16 although either has shown the 
effectiveness in the previous experiments. 29' 31 (3) 
The lung injury model was different. It is conceiv- 
able that lung injury in this study was more severe 
than that in our previous canine model and thus 
NAC may not have been able to attenuate the injury 
of a greater insult. 
Previously we reported a new method for 
measuring active oxygens that makes use of 
chemiluminescence of cypridina luciferin analogs, 
2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyra- 
zin-3-0ne (CLA) and MCLA. 19 MCLA reacts with 
02-  or 10 2 to yield a dioxetane analog that 
decarboxylates and protonates to an excited car- 
bonyl compound that emits light strongly near 465 
nm during its return to ground state. 32 The lumi- 
nescence level in the hTRX group was signifi- 
cantly lower than that in the control group and 
appeared to be similar to the level of the SOD 
group used as a positive control. These results 
suggested that hTRX may reduce the generation 
of active oxygens or eliminate them, which would 
result in the attenuation of ischemia-reperfusion 
injury in rabbit lungs. Because no significance was 
seen even between the control and the sham 
groups in our measurements of lipid peroxides, 
the chemiluminescence method appeared to be 
sufficiently sensitive to detect active oxygens. 
Our study does not elucidate the mechanism by 
which hTRX reduced active oxygens. It is likely that 
hTRX reduced active oxygen by scavenging action. 
There are some reports that suggest possible mech- 
anisms of hTRX. Mitsui, Harakawa, and Yodoi 14 
have proved that hTRX can reduce active oxygens 
induced by xanthine-xanthine oxidase in vitro. Iwata 
and associates is demonstrated that the administra- 
tion of hTRX increases the intracellular cystine 
uptake in cultured cells, suggesting that hTRX 
increase intracellular level of glutathione, which is 
orte of the most important antioxidants. Our col- 
league demonstrated that treatment with hTRX and 
/-cysteine attenuates i chemia-reperfusion injury in 
isolated rat lungs. 33 These studies support the hy- 
pothesis that hTRX might reduce active oxygens by 
increasing lutathione synthesis in pulmonary cells. 
Furthermore, thioredoxin-dependent peroxide re- 
ductase that uses thioredoxin as the immediate 
hydrogen donor was identified from yeast recently. 34 
Thioredoxin may be involved in thioredoxin-depen- 
dent radical-scavenging system with this protein. 
Further studies are needed to determine the rela- 
tionship among hTRX, active oxygens, and isch- 
emia-reperfusion lung injury. 
In conclusion, our study indicated that hTRX 
ameliorates ischemia-reperfusion injury in in vivo 
rabbit lungs, and this effect of hTRX may involve 
reducing active oxygens. It is hoped that these 
results will help clarify the mechanism of ischemia- 
reperfusion lung injury. 
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